New Delhi: Maintaining a steady supply of essential petrochemical inputs amid the West Asia conflict remains a concern for India's pharmaceutical industry, even though the government has waived customs duties on several of these products until June 30, according to industry executives. India's pharmaceutical industry faces ongoing concerns about securing essential petrochemical supplies due to the West Asia conflict. While a customs duty waiver offers some cost relief, industry experts highlight supply chain disruptions and timely movement as the primary challenges. The government's intervention aims to stabilize supply and lower input costs for critical sectors. (www.economictimes.indiatimes.com)

Source: Economic Times April 04, 2026 10:53 UTC